Cargando…

The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis

There is a largely divergent body of literature regarding the relationship between Epstein-Barr virus (EBV) infection and brain inflammation in multiple sclerosis (MS). Here, we tested MS patients during relapse (n = 11) and in remission (n = 19) in addition to n = 22 healthy controls to study the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wunsch, Marie, Hohmann, Christopher, Milles, Bianca, Rostermund, Christina, Lehmann, Paul V., Schroeter, Michael, Bayas, Antonios, Ulzheimer, Jochen, Mäurer, Mathias, Ergün, Süleyman, Kuerten, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848599/ https://www.ncbi.nlm.nih.gov/pubmed/27120609 http://dx.doi.org/10.3390/v8040105

Ejemplares similares

Categorization of multiple sclerosis relapse subtypes by B cell profiling in the blood
por: Hohmann, Christopher, et al.
Publicado: (2014)

CEACAM1 mediates B cell aggregation in central nervous system autoimmunity
por: Rovituso, Damiano M., et al.
Publicado: (2016)

The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients
por: Rovituso, Damiano M., et al.
Publicado: (2015)

Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
por: Bayas, Antonios, et al.
Publicado: (2015)

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis
por: Wunsch, Marie, et al.
Publicado: (2014)

The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2023)

Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
por: Rottlaender, Andrea, et al.
Publicado: (2015)

B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
por: Chunder, Rittika, et al.
Publicado: (2020)

Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
por: Enders, Michael, et al.
Publicado: (2020)

Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay
por: Wunsch, Marie, et al.
Publicado: (2015)

Large-scale cross-sectional online survey on patient-neurologist communication, burden of disease assessment and disease monitoring in people with multiple sclerosis
por: Christ, Monika, et al.
Publicado: (2023)

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021)

Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
por: Kuerten, Stefanie, et al.
Publicado: (2018)

IL-21 in Conjunction with Anti-CD40 and IL-4 Constitutes a Potent Polyclonal B Cell Stimulator for Monitoring Antigen-Specific Memory B Cells
por: Franke, Fridolin, et al.
Publicado: (2020)

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015)

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab
por: Ziemssen, Tjalf, et al.
Publicado: (2016)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
por: Bail, Kathrin, et al.
Publicado: (2017)

Resting of Cryopreserved PBMC Does Not Generally Benefit the Performance of Antigen-Specific T Cell ELISPOT Assays
por: Kuerten, Stefanie, et al.
Publicado: (2012)

Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2022)

The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2023)

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018)

Nav1.6 promotes inflammation and neuronal degeneration in a mouse model of multiple sclerosis
por: Alrashdi, Barakat, et al.
Publicado: (2019)

Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2022)

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials
por: Bayas, Antonios, et al.
Publicado: (2023)

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
por: Groß-Albenhausen, Elina, et al.
Publicado: (2023)

Contribution of LTi and T(H)17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis
por: Schropp, Verena, et al.
Publicado: (2019)

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis
por: Kolb-Mäurer, Annette, et al.
Publicado: (2015)

Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity
por: Wunsch, Marie, et al.
Publicado: (2015)

Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
por: Köppert, Sebastian, et al.
Publicado: (2021)

Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis
por: Breakell, Thomas, et al.
Publicado: (2020)

Delayed Activation Kinetics of Th2 and Th17 Cells Compared to Th1 Cells
por: Duechting, Andrea, et al.
Publicado: (2017)

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets
por: Gold, Ralf, et al.
Publicado: (2021)

Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
por: Simon, Micha, et al.
Publicado: (2018)

Obesity in Pediatric-Onset Multiple Sclerosis: A French Cohort Study
por: Milles, Pauline, et al.
Publicado: (2021)

Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis
por: Malyavantham, Kishore, et al.
Publicado: (2015)

Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
por: Bayas, A., et al.
Publicado: (2021)

The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity
por: Karle, Viktoria, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2012)

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
por: Kleist, Christian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i4i1ijjt76fque75nu6n1u5jf7